These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 20533297)

  • 1. Activin A and bone metastasis.
    Leto G
    J Cell Physiol; 2010 Nov; 225(2):302-9. PubMed ID: 20533297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activin is a potent growth suppressor of epithelial ovarian cancer cells.
    Ramachandran A; Marshall ES; Love DR; Baguley BC; Shelling AN
    Cancer Lett; 2009 Nov; 285(2):157-65. PubMed ID: 19493612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activins and cell migration.
    Kang HY; Shyr CR
    Vitam Horm; 2011; 85():129-48. PubMed ID: 21353879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of activin and BMP signaling.
    Harrison CA; Wiater E; Gray PC; Greenwald J; Choe S; Vale W
    Mol Cell Endocrinol; 2004 Oct; 225(1-2):19-24. PubMed ID: 15451563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonists of activin signaling: mechanisms and potential biological applications.
    Harrison CA; Gray PC; Vale WW; Robertson DM
    Trends Endocrinol Metab; 2005 Mar; 16(2):73-8. PubMed ID: 15734148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The activin axis in liver biology and disease.
    Rodgarkia-Dara C; Vejda S; Erlach N; Losert A; Bursch W; Berger W; Schulte-Hermann R; Grusch M
    Mutat Res; 2006; 613(2-3):123-37. PubMed ID: 16997617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activin A enhances prostate cancer cell migration through activation of androgen receptor and is overexpressed in metastatic prostate cancer.
    Kang HY; Huang HY; Hsieh CY; Li CF; Shyr CR; Tsai MY; Chang C; Chuang YC; Huang KE
    J Bone Miner Res; 2009 Jul; 24(7):1180-93. PubMed ID: 19257827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta in osteolytic breast cancer bone metastases.
    Guise TA; Chirgwin JM
    Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S32-8. PubMed ID: 14600590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activins and inhibins and their signaling.
    Vale W; Wiater E; Gray P; Harrison C; Bilezikjian L; Choe S
    Ann N Y Acad Sci; 2004 Dec; 1038():142-7. PubMed ID: 15838109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of activin, transforming growth factor-beta and bone morphogenetic protein 15 in regulating zebrafish oocyte maturation.
    Tan Q; Balofsky A; Weisz K; Peng C
    Comp Biochem Physiol A Mol Integr Physiol; 2009 May; 153(1):18-23. PubMed ID: 18838125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis of oocyte-paracrine signalling that promotes granulosa cell proliferation.
    Gilchrist RB; Ritter LJ; Myllymaa S; Kaivo-Oja N; Dragovic RA; Hickey TE; Ritvos O; Mottershead DG
    J Cell Sci; 2006 Sep; 119(Pt 18):3811-21. PubMed ID: 16926195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-beta superfamily expression and actions in the endometrium and placenta.
    Jones RL; Stoikos C; Findlay JK; Salamonsen LA
    Reproduction; 2006 Aug; 132(2):217-32. PubMed ID: 16885531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of activins and follistatins in skin and hair follicle development and function.
    McDowall M; Edwards NM; Jahoda CA; Hynd PI
    Cytokine Growth Factor Rev; 2008; 19(5-6):415-26. PubMed ID: 18922734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microarray analysis of bone morphogenetic protein, transforming growth factor beta, and activin early response genes during osteoblastic cell differentiation.
    de Jong DS; van Zoelen EJ; Bauerschmidt S; Olijve W; Steegenga WT
    J Bone Miner Res; 2002 Dec; 17(12):2119-29. PubMed ID: 12469906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice.
    Goumans MJ; Mummery C
    Int J Dev Biol; 2000 Apr; 44(3):253-65. PubMed ID: 10853822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A molecular recognition paradigm: promiscuity associated with the ligand-receptor interactions of the activin members of the TGF-beta superfamily.
    Keah HH; Hearn MT
    J Mol Recognit; 2005; 18(5):385-403. PubMed ID: 15948132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of bone morphogenetic proteins (BMPs), their receptors, and activins in normal and scarred conjunctiva: role of BMP-6 and activin-A in conjunctival scarring?
    Andreev K; Zenkel M; Kruse F; Jünemann A; Schlötzer-Schrehardt U
    Exp Eye Res; 2006 Nov; 83(5):1162-70. PubMed ID: 16879818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transforming growth factor-beta superfamily in the regulation of new bone formation].
    Li X; Huang X; Qi ZL; Wang W
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2002 Mar; 16(2):126-9. PubMed ID: 11944520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activins and activin antagonists in the human ovary and ovarian cancer.
    Reader KL; Gold E
    Mol Cell Endocrinol; 2015 Nov; 415():126-32. PubMed ID: 26277402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the inhibin/activin system and luteinizing hormone in adrenocortical tumorigenesis.
    Beuschlein F; Looyenga BD; Reincke M; Hammer GD
    Horm Metab Res; 2004 Jun; 36(6):392-6. PubMed ID: 15241730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.